A personalized Uncertainty Quantification framework for patient survival models: estimating individual uncertainty of patients with metastatic brain tumors in the absence of ground truth

no code implementations • 28 Nov 2023 • Yuqi Wang, Aarzu Gupta, David Carpenter, Trey Mullikin, Zachary J. Reitman, Scott Floyd, John Kirkpatrick, Joseph K. Salama, Paul W. Sperduto, Jian-Guo Liu, Mustafa R. Bashir, Kyle J. Lafata

We evaluated our method on multiple clinically-relevant endpoints, including time to intracranial progression (ICP), progression-free survival (PFS) after SRS, overall survival (OS), and time to ICP and/or death (ICPD), on a variety of both statistical and non-statistical models, including CoxPH, conditional survival forest (CSF), and neural multi-task linear regression (NMTLR).

Time-to-Event Prediction Uncertainty Quantification

The ASNR-MICCAI Brain Tumor Segmentation (BraTS) Challenge 2023: Intracranial Meningioma

no code implementations • 12 May 2023 • Dominic LaBella, Maruf Adewole, Michelle Alonso-Basanta, Talissa Altes, Syed Muhammad Anwar, Ujjwal Baid, Timothy Bergquist, Radhika Bhalerao, Sully Chen, Verena Chung, Gian-Marco Conte, Farouk Dako, James Eddy, Ivan Ezhov, Devon Godfrey, Fathi Hilal, Ariana Familiar, Keyvan Farahani, Juan Eugenio Iglesias, Zhifan Jiang, Elaine Johanson, Anahita Fathi Kazerooni, Collin Kent, John Kirkpatrick, Florian Kofler, Koen van Leemput, Hongwei Bran Li, Xinyang Liu, Aria Mahtabfar, Shan McBurney-Lin, Ryan McLean, Zeke Meier, Ahmed W Moawad, John Mongan, Pierre Nedelec, Maxence Pajot, Marie Piraud, Arif Rashid, Zachary Reitman, Russell Takeshi Shinohara, Yury Velichko, Chunhao Wang, Pranav Warman, Walter Wiggins, Mariam Aboian, Jake Albrecht, Udunna Anazodo, Spyridon Bakas, Adam Flanders, Anastasia Janas, Goldey Khanna, Marius George Linguraru, Bjoern Menze, Ayman Nada, Andreas M Rauschecker, Jeff Rudie, Nourel Hoda Tahon, Javier Villanueva-Meyer, Benedikt Wiestler, Evan Calabrese

Meningiomas are the most common primary intracranial tumor in adults and can be associated with significant morbidity and mortality.

Brain Image Segmentation Brain Tumor Segmentation +3